![]() |
市場調查報告書
商品編碼
1949548
蒸氣高壓釜市場 - 全球產業規模、佔有率、趨勢、機會及預測(按類型、應用、地區和競爭格局分類,2021-2031年)Steam Autoclaves Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Configuration, By Application (Medical Steam Autoclaves, Dental Steam Autoclaves, Laboratory Steam Autoclaves), By Region & Competition, 2021-2031F |
||||||
全球蒸氣高壓釜市場預計將從 2025 年的 15.9 億美元成長到 2031 年的 22.8 億美元,複合年成長率為 6.19%。
蒸氣高壓釜是一種特殊的加壓容器,利用高壓飽和蒸氣對工業和醫療設備進行消毒滅菌,從而消除微生物。推動全球市場發展的關鍵因素是醫療相關感染的日益增多以及醫療機構對安全通訊協定的嚴格執行,這都要求採用高效的滅菌流程。世界衛生組織(WHO)估計,到2024年,全球每年將有約1.36億例抗藥性醫療相關感染,凸顯了可靠的滅菌方法對於保障病患安全和對抗抗菌素抗藥性的重要性。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 15.9億美元 |
| 市場規模:2031年 | 22.8億美元 |
| 複合年成長率:2026-2031年 | 6.19% |
| 成長最快的細分市場 | 直立式高壓釜 |
| 最大的市場 | 北美洲 |
蒸氣高壓釜市場進一步擴張的主要挑戰之一是蒸氣滅菌與先進醫療設備中常用的熱敏材料不相容。許多現代手術器械都包含易受高溫高濕環境劣化的精密電子元件和塑膠,這迫使醫療機構採用環氧乙烷和等離子體等其他低溫滅菌技術。這項限制使得蒸氣高壓釜的應用僅限於耐熱器械,並要求醫療機構投資多種滅菌方法,從而增加營運預算負擔。
診斷和外科手術量的增加是蒸氣高壓釜需求的主要促進因素。隨著患者數量的增加,快速滅菌循環對於維持器械的可用性至關重要。醫院和門診中心正面臨前所未有的容量需求,促使各機構升級到更高容量的系統,以便能夠處理大量手術托盤而不會出現營運瓶頸。近期統計數據量化了臨床活動的激增。根據美國醫院協會 (AHA) 於 2025 年 1 月發布的報告《2025 年美國醫院速覽》,美國醫院總入院人數將達到約 3,450 萬,這凸顯了高效的滅菌基礎設施對於支持如此大規模的患者照護的重要性。
此外,製藥和生技領域研發活動的拓展也是市場成長的主要驅動力。嚴格的滅菌對於維持生物加工和藥物研發過程中的無菌條件至關重要,實驗室通常使用蒸氣高壓釜對培養基、玻璃器皿和生物危害廢棄物進行消毒。這可以防止交叉污染影響實驗的可靠性。 Fierce Biotech 於 2025 年 3 月發布的對主要製藥公司研發預算的分析表明,各公司在該領域的創新投入顯著。默克公司以 179 億美元的投資位居榜首,顯示其在設備採購方面投入了大量資金。此外,STERIS plc 在 2025 年 5 月的新聞稿中宣布,其全年營收成長 6% 至 55 億美元,顯示全球對感染預防解決方案的需求持續旺盛。
全球蒸氣高壓釜市場成長的一大挑戰是蒸氣滅菌與現代醫療設備中使用的熱敏元件的材質不相容。蒸氣高壓釜的工作原理是將器械暴露於高溫高壓的飽和蒸氣中,該過程能有效滅菌耐用金屬,但劣化內視鏡等複雜器械中使用的敏感黏合劑、聚合物和電子元件。這種物理限制使得蒸氣高壓釜無法作為無菌處理領域的通用解決方案,從技術上限制了其效用。因此,醫療機構不得不將資本支出轉向其他低溫滅菌方法或外包服務,從而有效地縮小了蒸氣滅菌設備在更廣泛的滅菌生態系統中的潛在市場規模。
這種不相容性導致滅菌流程支離破碎,阻礙了蒸氣技術在日益成長的高級外科器械市場中佔有一席之地。依賴無法承受蒸氣循環的器械需要對各種再處理方法進行大量投資,這直接限制了標準高壓釜的可用性。根據醫療設備再處理協會 (AMDR) 統計,其成員公司在 2024 年向醫療機構提供了 3,630 萬件再處理過的醫療設備。如此龐大的庫存需要特殊的處理方法,而標準蒸氣循環難以滿足這些需求,這凸顯了由於熱力限制,蒸氣高壓釜無法覆蓋的巨大市場規模。
物聯網整合實現遠端監控,從根本上改變了全球蒸氣高壓釜市場,實現了即時連接和數據驅動的運作管理。越來越多的醫療機構部署智慧滅菌系統,這些系統能夠自動記錄循環參數和診斷分析結果,從而確保嚴格遵守安全標準,同時最大限度地降低人工記錄帶來的風險。這種向互聯基礎設施的轉變得到了各大行業聯盟的支持,這些聯盟在採購中優先考慮數位化準備。例如,Tatnauer 在 2025 年 1 月的新聞稿中宣布,其支援物聯網的 T-Top高壓釜獲得了 Premier 頒發的「技術突破」認證。 Premier 是一家醫療保健改進公司,服務約三分之二的美國醫療機構。
同時,全球嚴格的脫碳要求和降低營運成本的需求促使節能型熱回收系統成為關鍵發展趨勢。製造商正在開發採用先進資源回收架構的新一代高壓高壓釜,顯著降低蒸氣產生和腔室冷卻所需的水和能源消耗。這項技術變革直接得益於公司積極的永續性目標,這些目標影響著公司的產品創新方向。根據Getinge於2025年3月發布的2024年度報告,公司製定了到2030年將範圍1和範圍2溫室氣體絕對排放減少90%的戰略目標,這正推動公司加速其生態高效滅菌技術的商業化進程。
The Global Steam Autoclaves Market is projected to expand from USD 1.59 Billion in 2025 to USD 2.28 Billion by 2031, reflecting a compound annual growth rate of 6.19%. Steam autoclaves operate as specialized pressure chambers that utilize high-pressure saturated steam to decontaminate and sterilize industrial and medical equipment by eliminating microorganisms. The primary force driving this global market is the rising prevalence of healthcare-associated infections combined with the strict enforcement of safety protocols across medical facilities, which demand robust sterilization cycles. Highlighting this urgency, the World Health Organization estimated in 2024 that approximately 136 million antibiotic-resistant healthcare-associated infections occur globally each year, underscoring the critical need for reliable sterilization methods to ensure patient safety and combat antimicrobial resistance.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 1.59 Billion |
| Market Size 2031 | USD 2.28 Billion |
| CAGR 2026-2031 | 6.19% |
| Fastest Growing Segment | Vertical Stem Autoclaves |
| Largest Market | North America |
One significant challenge hindering the broader expansion of the steam autoclaves market is the incompatibility of steam sterilization with heat-sensitive materials prevalent in advanced medical devices. Many modern surgical instruments incorporate delicate electronics or plastics that degrade under high temperatures and moisture, compelling healthcare providers to adopt alternative low-temperature technologies such as ethylene oxide or plasma. This limitation confines the application of steam autoclaves to heat-resistant tools and requires facilities to invest in diverse sterilization methodologies, which can place a strain on operational budgets.
Market Driver
The increasing volume of diagnostic and surgical procedures acts as a primary catalyst for steam autoclave demand, as higher patient turnover necessitates rapid sterilization cycles to maintain instrument availability. Hospitals and outpatient centers are facing unprecedented throughput requirements, forcing facilities to upgrade to high-capacity systems capable of processing heavy loads of surgical trays without causing operational bottlenecks. This surge in clinical activity is quantified by recent statistics; according to the American Hospital Association's "Fast Facts on U.S. Hospitals, 2025" report from January 2025, total admissions in all U.S. hospitals reached nearly 34.5 million, emphasizing the critical need for efficient sterilization infrastructure to support this massive scale of patient care.
Additionally, the expansion of pharmaceutical and biotechnology R&D activities significantly drives market growth, as rigorous sterilization is mandatory for maintaining aseptic conditions during bioprocessing and drug discovery. Research laboratories depend heavily on steam autoclaves to decontaminate culture media, glassware, and biohazardous waste, ensuring that experimental integrity is not compromised by cross-contamination. This sector's investment in innovation is illustrated by Fierce Biotech's March 2025 analysis of top pharma R&D budgets, where Merck led with an investment of $17.9 billion, demonstrating the substantial capital supporting equipment procurement. Furthermore, STERIS plc reported in its May 2025 press release that full-year revenue increased 6% to $5.5 billion, indicating sustained global demand for infection prevention solutions.
Market Challenge
A significant challenge impeding the growth of the Global Steam Autoclaves Market is the material incompatibility of steam sterilization with heat-sensitive components found in modern medical instrumentation. Steam autoclaves function by subjecting instruments to high-pressure saturated steam at elevated temperatures, a process that effectively sterilizes durable metals but degrades delicate adhesives, polymers, and electronics used in complex devices like endoscopes. This physical limitation restricts steam autoclaves from serving as a universal solution for sterile processing departments, creating a technical ceiling on their utility. Consequently, healthcare facilities are compelled to divert capital expenditure toward alternative low-temperature modalities or outsourced services, effectively shrinking the addressable market for steam-based equipment within the broader sterilization ecosystem.
This incompatibility forces a fragmentation of sterilization workflows, preventing steam technology from capturing the growing segment of advanced surgical tools. The reliance on devices that cannot withstand steam cycles necessitates substantial investment in diverse reprocessing methodologies, directly limiting the procurement of standard autoclaves. According to the Association of Medical Device Reprocessors, member companies supplied 36.3 million reprocessed medical devices to healthcare facilities in 2024. This substantial volume of inventory, which requires specialized handling often outside the capabilities of standard steam cycles, underscores the magnitude of the market segment that steam autoclaves fail to capture due to thermal limitations.
Market Trends
The integration of IoT for remote monitoring and control is fundamentally reshaping the Global Steam Autoclaves Market by enabling real-time connectivity and data-driven operational management. Facilities are increasingly deploying smart sterilization systems that automatically capture cycle parameters and diagnostic analytics, thereby ensuring strict compliance with safety standards while minimizing the risks associated with manual record-keeping. This transition towards connected infrastructure is validated by major industry alliances that prioritize digital readiness in procurement; for instance, Tuttnauer announced in a January 2025 press release that its IoT-enabled T-Top Autoclaves received a technology breakthrough designation from Premier, Inc., a healthcare improvement company serving approximately two-thirds of all U.S. healthcare providers.
Simultaneously, the development of energy-efficient heat recovery systems has emerged as a critical trend driven by stringent global decarbonization mandates and the need to reduce operational expenditures. Manufacturers are engineering next-generation autoclaves featuring advanced resource recovery architectures that significantly lower the water and energy intensity required for steam generation and chamber cooling. This engineering shift is directly supported by aggressive corporate sustainability goals influencing product innovation pipelines; according to Getinge's "Annual Report 2024" published in March 2025, the company has committed to a strategic target of reducing its absolute Scope 1 and 2 greenhouse gas emissions by 90% by 2030, a directive that is accelerating the commercialization of their eco-efficient sterilization technologies.
Report Scope
In this report, the Global Steam Autoclaves Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Steam Autoclaves Market.
Global Steam Autoclaves Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: